Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Discipline keeps budgets on track amid temptations to overspend. Learn why steady habits matter and how to cultivate them for lasting budgeting success.
23,814 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Amazon Web Services released a landmark study on AI agent drift, arguing that the link between models and tools needs...
As AI data centers surge, the race for reliable, green energy accelerates. This analysis explains how Oklo could beco...
A new recession indicator signals Americans are financially tighter than forecasts suggested. This article breaks dow...
Public crises don’t just steal headlines—they can drain bank accounts and disrupt daily budgets. This guide explains ...
Companies are ditching token-based performance dashboards as ROI from AI pivots to concrete business outcomes like re...
A single mobile title is proving that AI hype can’t single-handedly replace human creativity. This billion-dollar bea...
SoFi is betting big on product innovation to lift growth. This deep dive explains what the latest move could mean for...
Biotech investing hinges on milestones and discipline. This article breaks down inmune (INMB) 2025 earnings, what the...
If SpaceX goes public, investors will chase big headlines and big moves. History suggests year-one volatility is the ...
Whop, a $1.6B social commerce platform, reports more than 650 millionaires minted and unveils new programs to turn pa...
Could Palantir’s stock be meaningfully higher by 2027? This article offers a grounded forecast with base, bull, and b...